98896-96-9 Usage
Thiazolidine derivative
A five-membered ring containing sulfur and nitrogen atoms
The compound has a five-membered ring structure with sulfur and nitrogen atoms as part of the core structure, which classifies it as a thiazolidine derivative.
Phenolic hydroxyl group
A hydroxyl group (-OH) attached to the phenyl ring
The compound contains a hydroxyl group on the phenyl ring, which is characteristic of phenolic compounds and may contribute to its biological activity.
Methoxy group
An oxygen atom attached to the phenyl ring via a methyl group (-OCH3)
The presence of a methoxy group on the phenyl ring can influence the compound's properties, such as solubility and reactivity, and may also contribute to its biological activity.
Potential applications in pharmaceutical research
Antioxidant, antidiabetic, and anti-inflammatory properties
Thiazolidine derivatives, including 2-(4-hydroxy-3-methoxyphenyl)thiazolidine, have been studied for their various biological activities, making them potential candidates for pharmaceutical development.
Antioxidant and free radical scavenging activities
Due to the presence of phenolic and methoxy groups
The phenolic and methoxy groups in the compound suggest that it may have antioxidant and free radical scavenging activities, which could be useful in the development of new pharmaceuticals targeting various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 98896-96-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,8,9 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 98896-96:
(7*9)+(6*8)+(5*8)+(4*9)+(3*6)+(2*9)+(1*6)=229
229 % 10 = 9
So 98896-96-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2S/c1-13-9-6-7(2-3-8(9)12)10-11-4-5-14-10/h2-3,6,10-12H,4-5H2,1H3
98896-96-9Relevant articles and documents
Platelet anti-aggregant activity of 2,2-dimethylthiazolidine hydrochloride and 2-(4-hydroxy-3-methoxyphenyl)thiazolidine
Mimura,Kohama,Kuwahara,Yamamoto,Komiyama,Satake,Chiba,Miyashita,Tanaka,Imanishi,Iwata
, p. 1110 - 1116 (1988)
-
NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES
-
Page 58, (2010/02/09)
Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.
